Born from a Personal Journey.
Driven by Innovation.
MyelinZ began with a mission to transform lives through neurotechnology. Today, it’s a movement redefining brain and body performance, one breakthrough at a time.
Our Mission:
Redefining Brain Health
Dr Zied Tayeb founded MyelinZ, inspired by his mother’s fight against a neurological condition, to revolutionise brain health and help people overcome cognitive, mental, and physical challenges.

Vision:
Pioneering a New Era of Brain Health
Empowering millions to reclaim their cognitive and physical well-being.
Meet Our Leadership Team
Globally dispersed, united by one mission—to develop neurotechnology that redefines brain health and unlocks human potential.

Co-Founder & CEO
Dr Zied Tayeb

Co-Founder & CTO
Samaher Garbaya
Meet Our Experts
World-class experts guiding our mission to revolutionise brain health and unlock human potential through groundbreaking brain-computer interfaces.
Our Awards
MyelinZ at the UK Parliament (House of Commons)

MyelinZ presenting at the Belgian Ambassador’s Residence in the UK
.jpeg)
MyelinZ at Y Combinator London Event
.jpeg)
MedTech Rising Star Of The Year 2024
.jpeg?alt=media&token=81b99798-775a-4da6-a67f-05ec5b1671cf)
MedTech Rising Star Of The Year 2024
.jpeg?alt=media&token=de2d907f-ef63-463a-a27f-d4c36649d27d)
MyelinZ starting a collaboration with NYU Langone
.jpeg?alt=media&token=1080285e-987b-4ed9-890a-c3ef9fc7eff8)
The R-MMS product clinical trial lanuch.
.jpeg?alt=media&token=4a4a24f9-93a2-47b4-93cc-294fcc674b3d)
The MyelinSpace product exhibition at IAC 2024.
.jpeg?alt=media&token=bf30defb-ff17-46a1-9e9f-0ca67941986c)
Founders touring various embassies around the world
.jpeg?alt=media&token=6b516724-0c4a-4773-8918-16788b4dd547)
Founders touring various embassies around the world

MyelinZ Winter Retreat 2025
The MyelinZ Voyage
So Far...
- 2021
Initial technology development - Q1-2024
R&D funding & pre-seed funding - Q2-2024
Clinical trial for R-MMS (a medical device for MS) is approved and funded. - December 2024
The creation of the MyelinZ Group, launching a portfolio of three innovative products: ○ R-MMS: A medical device for MS. ○ BodyMirror: a brain health and wellbeing product, described as 'the new gym for the brain'. ○ MyelinSpace: transforming brain health in space - December 2024
Five US patents and trademarks are filed. - January 2025
MyelinZ signs three collaboration agreements with top global medical institutions to pilot BodyMirror. - Q3-2025
Q3-2025 BodyMirror Soft Launch
Disclaimer: MyelinZ products, including BodyMirror technology, are intended for research applications and personal use only. Our products are not classified as Medical Devices under EU Directive 93/42/EEC and are not designed or intended for the diagnosis or treatment of any disease.
©2025 MyelinZ, All rights reserved.